Incyte Corp. (INCY)
111.36
-1.43
(-1.27%)
USD |
NASDAQ |
Oct 12, 16:00
108.00
-3.36
(-3.02%)
After-Hours: 20:00
Incyte Net Income (TTM) : 1.612B for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.612B |
| March 31, 2026 | 1.432B |
| December 31, 2025 | 1.287B |
| September 30, 2025 | 1.189B |
| June 30, 2025 | 870.87M |
| March 31, 2025 | 21.27M |
| December 31, 2024 | 32.62M |
| September 30, 2024 | 32.48M |
| June 30, 2024 | 97.30M |
| March 31, 2024 | 745.44M |
| December 31, 2023 | 597.60M |
| September 30, 2023 | 424.98M |
| June 30, 2023 | 366.49M |
| March 31, 2023 | 324.37M |
| December 31, 2022 | 340.66M |
| September 30, 2022 | 876.05M |
| June 30, 2022 | 945.01M |
| March 31, 2022 | 933.04M |
| December 31, 2021 | 948.58M |
| September 30, 2021 | 534.58M |
| June 30, 2021 | 337.64M |
| March 31, 2021 | 478.48M |
| December 31, 2020 | -295.70M |
| September 30, 2020 | -334.54M |
| June 30, 2020 | -191.07M |
| Date | Value |
|---|---|
| March 31, 2020 | -376.05M |
| December 31, 2019 | 446.91M |
| September 30, 2019 | 404.96M |
| June 30, 2019 | 305.87M |
| March 31, 2019 | 252.94M |
| December 31, 2018 | 109.49M |
| September 30, 2018 | -109.20M |
| June 30, 2018 | -102.32M |
| March 31, 2018 | -167.20M |
| December 31, 2017 | -313.14M |
| September 30, 2017 | -154.64M |
| June 30, 2017 | -153.82M |
| March 31, 2017 | -106.91M |
| December 31, 2016 | 104.22M |
| September 30, 2016 | 150.53M |
| June 30, 2016 | 74.07M |
| March 31, 2016 | 48.94M |
| December 31, 2015 | 6.531M |
| September 30, 2015 | -85.59M |
| June 30, 2015 | 13.28M |
| March 31, 2015 | -32.88M |
| December 31, 2014 | -48.48M |
| September 30, 2014 | -54.41M |
| June 30, 2014 | -135.74M |
| March 31, 2014 | -101.44M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 4.329B |
| Mirum Pharmaceuticals, Inc. | -860.21M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| Vertex Pharmaceuticals, Inc. | 4.405B |
| AbbVie, Inc. | 6.274B |